Shell Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.54M | Sell |
2,416
-1,361
| -36% | -$826K | 0.16% | 147 |
|
|
2025
Q2 | $2.03M | Buy |
3,777
+2,080
| +123% | +$995K | 0.07% | 262 |
|
|
2025
Q1 | $713K | Sell |
1,697
-88
| -5% | -$38.2K | 0.03% | 367 |
|
|
2024
Q4 | $738K | Sell |
1,785
-48
| -3% | -$21.1K | 0.03% | 380 |
|
|
2024
Q3 | $926K | Buy |
+1,833
| New | +$890K | 0.04% | 328 |
|
|
2024
Q1 | $893K | Sell |
1,833
-1,570
| -46% | -$858K | 0.04% | 321 |
|
|
2023
Q4 | $1.89M | Sell |
3,403
-920
| -21% | -$432K | 0.09% | 228 |
|
|
2023
Q3 | $1.89M | Sell |
4,323
-72
| -2% | -$35.9K | 0.08% | 245 |
|
|
2023
Q2 | $2.21M | Sell |
4,395
-692
| -14% | -$332K | 0.09% | 231 |
|
|
2023
Q1 | $2.54M | Sell |
5,087
-64
| -1% | -$30.6K | 0.11% | 198 |
|
|
2022
Q4 | $2.1M | Sell |
5,151
-909
| -15% | -$353K | 0.09% | 230 |
|
|
2022
Q3 | $1.97M | Sell |
6,060
-1,709
| -22% | -$628K | 0.08% | 250 |
|
|
2022
Q2 | $2.73M | Buy |
7,769
+823
| +12% | +$336K | 0.08% | 243 |
|
|
2022
Q1 | $3.8M | Sell |
6,946
-1,625
| -19% | -$855K | 0.09% | 220 |
|
|
2021
Q4 | $5.64M | Buy |
8,571
+1,240
| +17% | +$778K | 0.12% | 176 |
|
|
2021
Q3 | $4.56M | Buy |
7,331
+635
| +9% | +$427K | 0.1% | 205 |
|
|
2021
Q2 | $4.23M | Buy |
6,696
+1,543
| +30% | +$852K | 0.08% | 247 |
|
|
2021
Q1 | $2.52M | Buy |
5,153
+410
| +9% | +$205K | 0.05% | 316 |
|
|
2020
Q4 | $2.37M | Buy |
4,743
+1,278
| +37% | +$572K | 0.05% | 360 |
|
|
2020
Q3 | $1.36M | Buy |
3,465
+296
| +9% | +$109K | 0.03% | 400 |
|
|
2020
Q2 | $1.05M | Sell |
3,169
-597
| -16% | -$173K | 0.03% | 425 |
|
|
2020
Q1 | $912K | Sell |
3,766
-300
| -7% | -$78.3K | 0.03% | 459 |
|
|
2019
Q4 | $1.06M | Sell |
4,066
-1,038
| -20% | -$274K | 0.02% | 531 |
|
|
2019
Q3 | $1.39M | Hold |
5,104
| – | – | 0.03% | 423 |
|
|
2019
Q2 | $1.41M | Buy |
5,104
+155
| +3% | +$38.2K | 0.03% | 438 |
|
|
2019
Q1 | $1.11M | Hold |
4,949
| – | – | 0.02% | 515 |
|
|
2018
Q4 | $921K | Sell |
4,949
-1,481
| -23% | -$304K | 0.02% | 555 |
|
|
2018
Q3 | $1.6M | Sell |
6,430
-26
| -0.4% | -$6.31K | 0.03% | 451 |
|
|
2018
Q2 | $1.41M | Buy |
6,456
+1,216
| +23% | +$251K | 0.03% | 510 |
|
|
2018
Q1 | $1M | Buy |
5,240
+805
| +18% | +$149K | 0.02% | 666 |
|
|
2017
Q4 | $694K | Buy |
4,435
+575
| +15% | +$90.5K | 0.01% | 797 |
|
|
2017
Q3 | $600K | Sell |
3,860
-1,228
| -24% | -$194K | 0.01% | 797 |
|
|
2017
Q2 | $821K | Hold |
5,088
| – | – | 0.02% | 733 |
|
|
2017
Q1 | $787K | Buy |
5,088
+165
| +3% | +$22.7K | 0.02% | 746 |
|
|
2016
Q4 | $577K | Sell |
4,923
-2,714
| -36% | -$310K | 0.01% | 836 |
|
|
2016
Q3 | $861K | Buy |
7,637
+36
| +0.5% | +$3.79K | 0.02% | 704 |
|
|
2016
Q2 | $706K | Buy |
+7,601
| New | +$653K | 0.02% | 657 |
|
|
2015
Q3 | – | Sell |
-2,606
| Closed | -$167K | – | 868 |
|
|
2015
Q2 | $167K | Buy |
+2,606
| New | +$180K | ﹤0.01% | 837 |
|
Other funds holding IDXX
Shell Asset Management's IDXX Position: Q3 2025 in Review
Shell Asset Management reduced its Idexx Laboratories (IDXX) stake by 36% in Q3 2025, selling an estimated $826K and leaving 2,416 shares worth $1.54M. The position accounts for 0.16% of the portfolio, ranked #147.
Shell Asset Management first reported a position in IDXX in Q2 2015 and has held it in 38 quarters since. The position peaked at $5.64M in Q4 2021. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.
- Shell Asset Management held 2,416 shares of Idexx Laboratories worth $1.54M as of Q3 2025.
- Shell Asset Management sold 1,361 Idexx Laboratories shares in Q3 2025, an estimated $826K.
- Idexx Laboratories made up 0.16% of Shell Asset Management's portfolio in Q3 2025, its #147 holding.
- Shell Asset Management first reported a position in Idexx Laboratories in Q2 2015 and has held it in 38 quarters since.
- Shell Asset Management's Idexx Laboratories position peaked at $5.64M in Q4 2021.
- 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.